308 related articles for article (PubMed ID: 27655283)
61. Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats.
Wen S; Li Z; Feng J; Bai J; Lin X; Huang H
Cancer Sci; 2016 Jun; 107(6):836-45. PubMed ID: 27019331
[TBL] [Abstract][Full Text] [Related]
62. LC-MS untargeted metabolomics assesses the delayed response of glufosinate treatment of transgenic glufosinate resistant (GR) buffalo grasses (Stenotaphrum secundatum L.).
Boonchaisri S; Rochfort S; Stevenson T; Dias DA
Metabolomics; 2021 Feb; 17(3):28. PubMed ID: 33609206
[TBL] [Abstract][Full Text] [Related]
63. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.
Karasek P; Gablo N; Hlavsa J; Kiss I; Vychytilova-Faltejskova P; Hermanova M; Kala Z; Slaby O; Prochazka V
Cancer Genomics Proteomics; 2018; 15(4):321-327. PubMed ID: 29976637
[TBL] [Abstract][Full Text] [Related]
64. Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival.
Holm M; Saraswat M; Joenväärä S; Seppänen H; Renkonen R; Haglund C
Tumour Biol; 2020 Jun; 42(6):1010428320936410. PubMed ID: 32586207
[TBL] [Abstract][Full Text] [Related]
65. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
[TBL] [Abstract][Full Text] [Related]
66. Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy.
Kruger D; Yako YY; Devar J; Lahoud N; Smith M
PLoS One; 2019; 14(8):e0221169. PubMed ID: 31415645
[TBL] [Abstract][Full Text] [Related]
67. Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma.
Poruk KE; Firpo MA; Huerter LM; Scaife CL; Emerson LL; Boucher KM; Jones KA; Mulvihill SJ
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2605-10. PubMed ID: 20729288
[TBL] [Abstract][Full Text] [Related]
68. Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer.
Wang W; Tian X; Yan L; Guan X; Dong B; Zhao M; Liu D; Wu J; Hao C
Ann Med; 2023; 55(2):2242247. PubMed ID: 37544888
[TBL] [Abstract][Full Text] [Related]
69. Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.
Riva F; Dronov OI; Khomenko DI; Huguet F; Louvet C; Mariani P; Stern MH; Lantz O; Proudhon C; Pierga JY; Bidard FC
Mol Oncol; 2016 Mar; 10(3):481-93. PubMed ID: 26856794
[TBL] [Abstract][Full Text] [Related]
70. Assessment of Untargeted Metabolomics by Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry to Define Breast Cancer Liquid Biopsy-Based Biomarkers in Plasma Samples.
González Olmedo C; Díaz Beltrán L; Madrid García V; Palacios Ferrer JL; Cano Jiménez A; Urbano Cubero R; Pérez Del Palacio J; Díaz C; Vicente F; Sánchez Rovira P
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791138
[TBL] [Abstract][Full Text] [Related]
71. Analysis of Brain Metabolites Using Two Complementary Ultrahigh-Performance Liquid Chromatography-Mass Spectrometry Methods.
Jauregui AM; Parellada SE; Neag E; Bhattacharya SK
Methods Mol Biol; 2023; 2571():133-142. PubMed ID: 36152157
[TBL] [Abstract][Full Text] [Related]
72. Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?
Liu DSK; Mato Prado M; Giovannetti E; Jiao LR; Krell J; Frampton AE
Expert Rev Mol Diagn; 2019 Jul; 19(7):553-558. PubMed ID: 31159604
[No Abstract] [Full Text] [Related]
73. Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease.
Stålberg SM; Silwal-Pandit L; Bastani NE; Nebdal DJH; Lingjærde OC; Skålhegg BS; Kure EH
BMC Cancer; 2024 May; 24(1):555. PubMed ID: 38702616
[TBL] [Abstract][Full Text] [Related]
74. No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay.
Liberati D; Marzinotto I; Brigatti C; Dugnani E; Pasquale V; Reni M; Balzano G; Falconi M; Piemonti L; Lampasona V
Cancer Biomark; 2018; 22(2):351-357. PubMed ID: 29660901
[TBL] [Abstract][Full Text] [Related]
75. PSMD11, PTPRM and PTPRB as novel biomarkers of pancreatic cancer progression.
Sahni S; Krisp C; Molloy MP; Nahm C; Maloney S; Gillson J; Gill AJ; Samra J; Mittal A
Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129682. PubMed ID: 32663515
[TBL] [Abstract][Full Text] [Related]
76. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
Nesteruk K; Levink IJM; de Vries E; Visser IJ; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
Pancreatology; 2022 Jun; 22(5):626-635. PubMed ID: 35613957
[TBL] [Abstract][Full Text] [Related]
77. Alternate reversed-phase and hydrophilic interaction liquid chromatography coupled with mass spectrometry for broad coverage in metabolomics analysis.
Lv W; Guo L; Zheng F; Wang Q; Wang W; Cui L; Ouyang Y; Liu X; Li E; Shi X; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122266. PubMed ID: 32693368
[TBL] [Abstract][Full Text] [Related]
78. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
[TBL] [Abstract][Full Text] [Related]
79. Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry.
Boudah S; Olivier MF; Aros-Calt S; Oliveira L; Fenaille F; Tabet JC; Junot C
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():34-47. PubMed ID: 24815365
[TBL] [Abstract][Full Text] [Related]
80. Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma.
Zhao J; Liang Y; Yin Q; Liu S; Wang Q; Tang Y; Cao C
Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27464025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
